news
Noninvasive therapy may reverse atherosclerosis
Researchers synthesized self-assembling peptide amphile nanofibers that targeted areas of plaque and could be delivered by intravenous injection...
List view / Grid view
Vaccines
news
FDA grants fast track designation for a Chikungunya vaccine
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
news
Sponsored trial of a universal influenza vaccine begins
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States...
news
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
news
New vaccine could help people overcome cathinone abuse
Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones...
news
Vaccine suppresses peanut allergies in mice
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
news
NIH scientists say advanced vaccines could limit future outbreaks
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
news
H7N9 influenza vaccine clinical trials begin
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States...
news
Antigen study provides a new approach to vaccine development for RSV
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
news
Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B
Tenofovir disoproxil fumarate (TDF) does not significantly reduce mother-to-child transmission of hepatitis B virus when taken during pregnancy and after delivery.
news
Strategic plan for developing a universal influenza vaccine unveiled
NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine...
news
Therapeutic gel shows promise against cancerous tumours
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
news
TB vaccine trial results offer potential for BCG revaccination
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
news
Gore to debut GORE™ ImproJect™ plunger for sensitive biologics in pre-filled syringes
NEWARK, Del. – W.L. Gore & Associates, Inc. (“Gore”), a global materials science company, will introduce its new GORE™ ImproJect™ Plunger at Pharmapack 2018, Europe's dedicated pharmaceutical packaging and drug delivery event. Gore will be in Booth A12 at the exhibition, to be held February 7 and 8, 2018, at…
news
Heroin vaccine blocks lethal overdose
Scientists have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug...
